Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 1;6(1):33.
doi: 10.1186/s40478-018-0531-3.

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease

Affiliations

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease

Sukriti Nag et al. Acta Neuropathol Commun. .

Abstract

TDP-43 pathology was investigated in the anterior temporal pole cortex (ATPC) and orbital frontal cortex (OFC), regions often degenerated in frontotemporal lobar degenerations (FTLD), in aging and Alzheimer's disease (AD). Diagnosis of dementia in the 1160 autopsied participants from 3 studies of community-dwelling elders was based on clinical evaluation and cognitive performance tests which were used to create summary measures of the five cognitive domains. Neuronal and glial TDP-43 cytoplasmic inclusions were quantitated in 8 brain regions by immunohistochemistry, and used in ANOVA and regression analyses. TDP-43 pathology was present in 547 (49.4%) participants in whom ATPC (41.9%) was the most frequently involved neocortical region and in 15.5% of these cases, ATPC was the only neocortical area with TDP-43 pathology suggesting not only that ATPC is involved early by TDP-43 but that ATPC may represent an intermediate stage between mesial temporal lobe involvement by TDP-43 and the last stage with involvement of other neocortical areas. To better study this intermediary neocortical stage, and to integrate with other staging schemes, our previous 3 stage distribution of TDP-43 pathology was revised to a 5 stage distribution scheme with stage 1 showing involvement of the amygdala only; stage 2 showed extension to hippocampus and/or entorhinal cortex; stage 3 showed extension to the ATPC; stage 4 - showed extension to the midtemporal cortex and/or OFC and finally in stage 5, there was extension to the midfrontal cortex. Clinically, cases in stages 2 to 5 had impaired episodic memory, however, stage 3 was distinct from stage 2 since stage 3 cases had significantly increased odds of dementia. The proportion of cases with hippocampal sclerosis increased progressively across the stages with stage 5 showing the largest proportion of hippocampal sclerosis cases. Stage 5 cases differed from other stages by having impairment of semantic memory and perceptual speed, in addition to episodic memory impairment. These data suggest that of the regions studied, TDP-43 pathology in the ATPC is an important early neocortical stage of TDP-43 progression in aging and AD while extension of TDP-43 pathology to the midfrontal cortex is a late stage associated with more severe and global cognitive impairment.

Keywords: Alzheimer’s disease; Anterior temporal pole; Dementia; Episodic memory; Hippocampal sclerosis; Orbital frontal cortex; Semantic memory; TDP-43.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Autopsied participants were from 3 longitudinal clinical-pathologic cohort studies of aging and dementia, Rush MAP, ROS and MARS, each approved by the Institutional Review Board of Rush University Medical Center. A signed, informed consent was obtained from each participant for an annual clinical evaluation and for brain donation.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
(a-g) The regional distribution of TDP-43 inclusions and percentage of cases showing TDP-43 inclusions in stages 1-5 are shown (a-g). This is a cumulative staging system such that any stage from 2 to 5 is considered to be positive if the previous stages are positive. The Brodmann designation of the cortices is shown in parentheses. AMG = amygdala, EC = entorhinal cortex, CA1 = CA1 sector of the hippocampus, DEN = dentate gyrus, ATPC = anterior temporal pole cortex, MTC = midtemporal cortex, OFC = orbital frontal cortex and MFC = midfrontal cortex
Fig. 2
Fig. 2
TDP-43 inclusions in neuronal cytoplasm and neurites in the ATPC are shown (a-d). Representative areas of the ATPC show sparse (a), moderate (b) and frequent (c) intracytoplasmic neuronal TDP-43 inclusions and neurite immunostaining. The areas depicted (a-c) are smaller than the 0.25 mm2 counting frame used to quantitate the inclusions. (d) Cytoplasmic TDP-43 in neurons and prominent neurite staining are shown in high magnification. Scale bar = 25 μm (a-c) and 50 μm (d)
Fig. 3
Fig. 3
Box plots showing the total number of TDP-43 inclusions per 0.25 mm2 area in the eight brain regions by stage. The numbers on the x axis denote the brain regions which are designated as 1: amygdala, 2: entorhinal cortex, 3:CA1 sector of the hippocampus, 4: dentate neurons of the hippocampus, 5: anterior temporal pole cortex, 6: midtemporal cortex, 7: orbital frontal cortex, 8: midfrontal cortex. There is progressive increase of inclusions in the amygdala by stage. Inclusions in all regions including the ATPC are maximal in stage 5

References

    1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602–611. doi: 10.1016/j.bbrc.2006.10.093. - DOI - PubMed
    1. Arnold SE, Hyman BT, Van Hoesen GW. Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. Arch Neurol. 1994;51:145–150. doi: 10.1001/archneur.1994.00540140051014. - DOI - PubMed
    1. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, Wilson RS. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27:169–176. doi: 10.1159/000096129. - DOI - PubMed
    1. Binder JR, Desai RH. The neurobiology of semantic memory. Trends Cogn Sci. 2011;15:527–536. doi: 10.1016/j.tics.2011.10.001. - DOI - PMC - PubMed
    1. Brettschneider J, Del TK, Irwin DJ, Grossman M, Robinson JL, Toledo JB, Fang L, Van Deerlin VM, Ludolph AC, Lee VM, Braak H, Trojanowski JQ. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) Acta Neuropathol. 2014;127:423–439. doi: 10.1007/s00401-013-1238-y. - DOI - PMC - PubMed

Publication types

MeSH terms